Deal to make Covid drug available to 3.8B folk set

By Agence France-Presse

Nov 18, 2021 12:08 am

GENEVA: US pharmaceutical giant Pfizer on Tuesday (Wednesday in Manila) announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries.

Pfizer will sublicense production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent (around 3.8 billion) of the world's population.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Rubio hit for calling NKorea 'rogue state'

China to propose restoring 'Phase 1' trade deal with US – WSJ

Floods force evacuations in northeast Australia

Policeman slain as drive vs polio starts in Pakistan

Singapore to migrant workers: Report kickbacks

Trump to talk with Canada, Mexico leaders over tariffs

Panama told: Cut China's influence on canal or else